This is an old revision of this page, as edited by Pustelnik (talk | contribs) at 11:08, 23 July 2008 (added to endocrinology). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
[[Category:]]
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Mecasermin" – news · newspapers · books · scholar · JSTOR (April 2008) (Learn how and when to remove this message) |
| Clinical data | |
|---|---|
| Routes of administration | Subcutaneous |
| Legal status | |
| Legal status |
|
Mecasermin, also known as mecasermin rinfabate (brand names Increlex and Iplex) is a growth hormone which is used for the long-term treatment of growth failure in children with severe primary IGF-1 deficiency.
Hypothalamic-pituitary hormones and analogues (H01) | |||||||
|---|---|---|---|---|---|---|---|
| Hypothalamus |
| ||||||
| Anterior pituitary |
| ||||||
| Posterior pituitary |
| ||||||
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
